20522 ⎘
Medicinal preparations containing organic active ingredients; Carbohydrates; Sugars; Derivatives thereof Compounds having saccharide radicals and heterocyclic rings
Sub-classes:INVARIANT NATURAL KILLER T-CELL ACTIVATORS
#2METHODS FOR TREATING CHOLESTASIS
#3COMPOSITIONS AND METHODS OF TREATING ACNE AND PHOTOAGING
#4BILE ACID RECYCLING INHIBITORS FOR TREATMENT OF HYPERCHOLEMIA AND CHOLESTATIC LIVER DISEASE
#5BILE ACID RECYCLING INHIBITORS FOR TREATMENT OF PEDIATRIC CHOLESTATIC LIVER DISEASES
#6METHODS OF IMPROVING RENAL FUNCTION
#7COMMENSAL BACTERIA PROMOTE ENDOCRINE-RESISTANCE IN PROSTATE CANCER VIA ANDROGEN BIOSYNTHESIS
#8TREATMENT OF METABOLIC DISORDERS IN EQUINE ANIMALS
#9COMBINATORIAL, AND ROTATIONAL COMBINATORIAL THERAPIES
#10METHODS OF IMPROVING RENAL FUNCTION
#11PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER, COMPRISING SGLT-2 INHIBITOR AND GOSSYPOL
#12FORMULATIONS OF VANCOMYCIN
#13METHODS AND COMPOSITIONS FOR PROVIDING MYOCARDIAL PROTECTION AND TREATING MYOCARDIAL STRESS AND FIBROSIS
#14Combination treatment and/or prevention of renal diseases and/or hypertension in non-human mammals comprising one or more SGLT-2 inhibitors and telmisartan
#15PHARMACEUTICAL COMPOSITIONS COMPRISING 2,3,4,5- TETRAHYDROBENZOTHIEPIN- 1,1-DIOXIDE DERIVATIVES AND THE USE THEREOF
#16INTESTINAL MICROBIOTA AND GVHD
#17TREATMENT OF HFPEF IN POST-MENOPAUSAL WOMEN WITH AN SGC STIMULATOR
#18THERAPEUTIC USE OF COMBINATION INCLUDING TRIPLE AGONIST HAVING ACTIVITIES TO ALL OF GLUCAGON, GLP-1, AND GIP RECEPTORS
#19ASBT INHIBITORS IN THE TREATMENT OF RENAL DISEASES
#20METHODS FOR TREATING CHOLESTASIS
#21SODIUM-DEPENDENT GLUCOSE TRANSPORTER 2 AS A DIAGNOSTIC AND THERAPEUTIC TARGET FOR PRE-MALIGNANT LESIONS
#22METHODS FOR TREATING CHOLESTASIS
#23COMPOSITIONS AND METHODS FOR PARENTERAL ADMINISTRATION OF THERAPEUTIC AGENTS
#24METHODS OF IMPROVING RENAL FUNCTION
#25USE OF SGLT-2 INHIBITORS FOR THE PREVENTION AND/OR TREAT-MENT OF CARDIAC DISEASES IN FELINES
#26AGENT FOR ELIMINATING SENESCENT CELLS
#27PHARMACEUTICAL COMPOSITIONS WITH LOW AMOUNTS OF NITROSAMINE IMPURITIES AND METHODS FOR PRODUCING THE SAME
#28METHODS FOR IMPROVING RENAL FUNCTION WITH A COMBINATION OF A BET BROMODOMAIN INHIBITOR AND A SODIUM DEPENDENT GLUCOSE TRANSPORT 2 INHIBITOR
#29AQUEOUS PHARMACEUTICAL COMPOSITIONS COMPRISING SGLT-2 INHIBITORS
#30Formulations of vancomycin
#31COMPOSITIONS AND METHODS OF TREATING ACNE AND PHOTOAGING
#32SGLT-2 INHIBITOR SARCOSINE CO-CRYSTAL, PREPARATION METHOD THEREFOR AND USE THEREOF
#33NOVEL PSYCHEDELIC COMPOSITIONS, DELIVERY SYSTEMS AND THERAPEUTIC USES THEREOF
#34Methods of improving renal function
#35Methods of improving renal function
#36USE OF SGLT-2 INHIBITORS IN THE DRYING-OFF OF NON-HUMAN MAMMALS
#37METHODS OF TREATING DIABETIC KIDNEY DISEASE
#38Bile acid recycling inhibitors for treatment of hypercholemia and cholestatic liver disease
#39Methods for treating cholestasis
#40BISMUTH-THIOLS AS ANTISEPTICS FOR EPITHELIAL TISSUES, ACUTE AND CHRONIC WOUNDS, BACTERIAL BIOFILMS AND OTHER INDICATIONS
#41TREATMENT OF METABOLIC DISORDERS IN FELINE ANIMALS
#42METHODS OF DOSING OF APICAL SODIUM-DEPENDENT BILE ACID TRANSPORTER INHIBITORS (ASBTIs)
#43METHODS OF IMPROVING RENAL FUNCTION
#44ANTIBODIES THAT DISRUPT THE INTERACTION OF GAL3 AND INSULIN RECEPTOR OR INTEGRINS AND METHODS OF USE THEREOF
#45COMPOUNDS AND METHODS FOR TREATING BACTERIAL INFECTIONS
#46ASCAROSIDE TREATMENT OF EOSINOPHILIC ESOPHAGITIS
#47URIDINE DIPHOSPHATE DERIVATIVES, PRODRUGS, COMPOSITIONS AND USES THEREOF
#48COMBINATION TREATMENT OF SYSTEMIC FUNGAL INFECTIONS
#49BILE ACID RECYCLING INHIBITORS AND SATIOGENS FOR TREATMENT OF DIABETES, OBESITY, AND INFLAMMATORY GASTROINTESTINAL CONDITIONS
#50Methods and compositions for increasing the dose of a chemotherapeutic agent
#51BILE ACID RECYCLING INHIBITORS FOR TREATMENT OF PEDIATRIC CHOLESTATIC LIVER DISEASES
#52COMBINATION TREATMENT OF LIVER DISEASES USING FXR AGONISTS
#53Fucosyltransferase specific inhibition using fucose mimetics
#54COMPOSITIONS AND METHODS FOR TREATING MICROBIOTA-RELATED PSYCHOTROPIC CONDITIONS AND DISEASES
#55COMPOSITIONS AND METHODS TO TREAT NON-ALCOHOLIC FATTY LIVER DISEASES (NAFLD)
#56METHODS FOR TREATING SUBJECTS WITH CHRONIC KIDNEY DISEASE
#57Mannose derivatives for treating bacterial infections
#58GENOTYPE AND DOSE-DEPENDENT RESPONSE TO AN ASBTI IN PATIENTS WITH BILE SALT EXPORT PUMP DEFICIENCY
#59Methods for treating cholestasis
#60SGLT-2 INHIBITORS OR IL-1R ANTAGONISTS FOR REDUCTION OF HYPOGLYCAEMIA AFTER BARIATRIC SURGERY
#61Use of canagliflozin in preparation of antitumor drug
#62OPHTHALMIC COMPOSITION CONTAINING DIQUAFOSOL OR SALT THEREOF, VINYL-BASED POLYMER AND CELLULOSE-BASED POLYMER
#63Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases
#64Methods Of Treating Diabetes In Severe Insulin-Resistant Diabetic Subjects
#65ASCAROSIDE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISEASES
#66TREATMENT AND PREVENTION OF CLOSTRIDIUM DIFFICILE COLITIS USING MISOPROSTOL
#67THERAPEUTIC USE OF GLUCAGON AND COMBINATION INCLUDING THE SAME
#68BIOACTIVE VITAMIN COMBINATIONS
#69Biomaterial and method for promoting tissue regeneration by using the biomaterial
#70ASCORBIC ACID, QUINONE COMPOUND, AND SODIUM GLUCOSE COTRANSPORTER INHIBITOR FOR TREATING CANCER
#71Use of SGLT-2 inhibitors for the prevention and/or treatment of cardiac diseases in felines
#72METHODS OF INHIBITION OF PROTEIN FUCOSYLATION IN VIVO USING FUCOSE ANALOGS
#73Bismuth-thiols as antiseptics for epithelial tissues, acute and chronic wounds, bacterial biofilms and other indications
#74Formulations of vancomycin
#75METHODS AND COMPOSITIONS FOR PREVENTING AND TREATING METABOLIC SYNDROME INDUCED BY ANTIPSYCHOTIC TREATMENT AND RELATED DISEASES AND CONDITIONS
#76Consumable Product Comprising Malted Wheat
#77CANAGLIFLOZIN MONOHYDRATE AND ITS CRYSTALLINE FORMS, PREPARATION METHODS AND USES THEREOF
#78Use of SGLT-2 inhibitors in the drying-off of non-human mammals
#79Agent for treating retinal disease
#80COMPOUNDS AND METHODS FOR TREATING BACTERIAL INFECTIONS
#81METHODS FOR THE TREATMENT AND PREVENTION OF RENAL DISORDERS AND FATTY LIVER DISORDERS
#82METHODS FOR TREATING CHOLESTASIS
#83Pharmaceutical composition comprising Canagliflozin, process of preparation and use thereof
#84Uridine diphosphate derivatives, prodrugs, compositions and uses thereof
#85TREATMENT OF METABOLIC DISORDERS IN EQUINE ANIMALS
#86METHODS FOR REDUCING OR PREVENTING CARDIOVASCULAR EVENTS IN PATIENTS WITH TYPE II DIABETES MELLITUS
#87METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT NEUROPATHY
#88Methods for treating cholestasis
#89Composition and methods of treating acne and photoaging
#902,7-dibromospiro[fluorene-9,4′-piperidine] compounds
#91CENICRIVIROC COMBINATION THERAPY FOR THE TREATMENT OF FIBROSIS
#92Compositions and methods for parenteral administration of therapeutic agents
#93Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases
#94TREATMENT OF METABOLIC DISORDERS IN EQUINE ANIMALS
#95Co-therapy comprising canagliflozin and phentermine for the treatment of obesity and obesity related disorders
#96BILE ACID RECYCLING INHIBITORS FOR TREATMENT OF HYPERCHOLEMIA AND CHOLESTATIC LIVER DISEASE
#97Treatment of metabolic disorders in feline animals
#98BILE ACID RECYCLING INHIBITORS FOR TREATMENT OF PEDIATRIC CHOLESTATIC LIVER DISEASES
#99Methods of inhibition of protein fucosylation in vivo using fucose analogs
#100Milk-Derived Microvesicle Compositions and Related Methods
#101Methods and compositions for the treatment of neuropathy and hyperalgesia
#102Formulations of vancomycin
#103DIABETES POLYGENIC RISK SCORE
#104Canagliflozin monohydrate and its crystalline forms, preparation methods and uses thereof
#105Compositions and methods for treating clostridium difficile infection
#106Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions
#107Agent for treating retinopathy
#108Ketolides having antibacterial activity
#109COMPOUNDS AND METHODS FOR TREATING BACTERIAL INFECTIONS
#110Bismuth-thiols as antiseptics for epithelial tissues, acute and chronic wounds, bacterial biofilms and other indications
#111Ascaroside treatment of eosinophilic esophagitis
#112Ascaroside treatment of autoimmune and inflammatory diseases
#113BILE ACID RECYCLING INHIBITORS FOR TREATMENT OF HYPERCHOLEMIA AND CHOLESTATIC LIVER DISEASE
#114CO-THERAPY COMPRISING CANAGLIFLOZIN AND PHENTERMINE FOR THE TREATMENT OF OBESITY AND OBESITY RELATED DISORDERS
#115Chemical structures for localized delivery of therapeutic agents
#116Mannose derivatives for treating bacterial infections
#117Modulators of SMAD7 expression
#118Pharmaceutical Composition Comprising Canagliflozin, Process of Preparation and Use Thereof
#119METHODS FOR THE TREATMENT AND PREVENTION OF RENAL DISORDERS AND FATTY LIVER DISORDERS
#120Compositions and methods of treating acne and photoaging
#121GLUCOPYRANOSIDE COMPOUND
#122Uridine diphosphate derivatives, prodrugs, compositions and uses thereof
#123Combination of bactericidal agent with a lysosomotropic alkalinising agent for the treatment of a bacterial infection
#124COMPOUNDS AND METHODS FOR TREATING BACTERIAL INFECTIONS
#125Milk-derived microvesicle compositions and related methods
#126Glucagon-like peptide 1 modulator and uses thereof
#127Treating infection by a platelet-targeting microbe using nanoparticles
#128Composition for amelioration of peri- and post-menopausal symptoms and a process for producing the same
#129COMPOSITIONS AND METHODS FOR TREATING MICROBIOTA-RELATED PSYCHOTROPIC CONDITIONS AND DISEASES
#130BILE ACID RECYCLING INHIBITORS FOR TREATMENT OF PEDIATRIC CHOLESTATIC LIVER DISEASES
#131COMBINATION OF CANAGLIFLOZIN AND PROBENECID FOR THE TREAMENT OF HYPERURICEMIA
#132BILAYER TABLET FORMULATIONS
#133Compounds and methods for treating bacterial infections
#134Combination treatment of SGLT2 inhibitors and dopamine agonists for preventing metabolic disorders in equine animals
#135Canagliflozin monohydrate and its crystalline forms, preparation methods and uses thereof
#136Anti-glycation methods and compositions
#137Combination therapy for the treatment of diabetes
#138Pharmaceutical formulations
#139CO-THERAPY COMPRISING CANAGLIFLOZIN AND PHENTERMINE FOR THE TREATMENT OF OBESITY AND OBESITY RELATED DISORDERS
#140Treatment of metabolic disorders in equine animals
#141Composition and methods of treating acne and photoaging
#142Methods of inhibition of protein fucosylation in vivo using fucose analogs
#143Herbicidal composition comprising flazasulfuron and an inhibitor of protoporphyrinogen oxidase
#144METHODS FOR THE TREATMENT AND PREVENTION OF RENAL DISORDERS AND FATTY LIVER DISORDERS
#145Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases
#146Uridine diphosphate derivatives, prodrugs, compositions and methods for treating neurodegenerative disorders
#147Mannose derivatives for treating bacterial infections
#148Targeting the EGFR-SGLT1 interaction for cancer therapy
#149Tablets containing a 1-(β-D-glucopyranosyl)-3-(phenylthienylmethyl)benzene compound
#150Uridine and uridine analogues for treatment of specific lung diseases, namely COPD and pulmonary fibrosis
#151Low-Sodium Effervescent Pharmaceutical Formulations
#152Compounds and methods for treating bacterial infections
#153Chemical structures for localized delivery of therapeutic agents
#154Sugar-linker-drug conjugates
#155Dosage and administration for preventing cardiotoxicity in treatment with ERbB2-targeted immunoliposomes comprising anthracycline chemotherapeutic agents
#156Methods for the preparation of diasteromerically pure phosphoramidate prodrugs
#157Anti-glycation methods and compositions
#158Milk-derived microvesicle compositions and related methods
#159Effective treatment of esophageal adenocarcinoma using triciribine and related compounds
#160Delphinidin for combating melanoma cells
#161Delphinidin for combating melanoma cells
#162Treatment of metabolic disorders in equine animals
#163Uridine diphosphate derivatives, prodrugs, compositions and uses thereof
#164Oligomeric compounds comprising tricyclic nucleosides and methods for their use
#165Bilayer tablet formulations
#166Methods for treating cancers using oral formulations of cytidine analogs
#167Compounds and methods for treating bacterial infections
#168Effective treatment of esophogeal adenocarcinoma using triciribine and related compounds
#169Urea compounds
#170Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions
#171COMBINATION THERAPY FOR THE TREATMENT OF DIABETES
#172Targeting the EGFR-SGLT1 interaction for cancer therapy
#173Tetrahydrobenzothiophene compound
#174Uridine and uridine analogues for treatment of specific lung diseases, namely COPD and pulmonary fibrosis
#175Nucleoside analogues for the treatment of a viral infection, and method for evaluating the sensitivity to said treatment
#176Bio-active antioxidants from plant foods for nutraceutical product development
#177Pharmaceutical composition containing honeysuckle extract and antibiotics, pharmaceutical kit, and use of honeysuckle extract for preparation of drug
#178Methods for treating glaucoma using uridine diphosphate derivatives
#1792′-substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
#180Ticagrelor co-crystal
#181Herbicidal composition comprising flazasulfuron and an inhibitor of protoporphyrinogen oxidase
#182Purine nucleoside monophosphate prodrugs for treatment of cancer and viral infections
#183Dosage and administration for preventing cardiotoxicity in treatment with ERBB2-targeted immunoliposomes comprising anthracycline chemotherapeutic agents
#184Bile Acid Recycling Inhibitors for Treatment of Pediatric Cholestatic Liver Diseases
#185Bilayer tablet formulations
#186Aryl glycoside compound, preparation method and use thereof
#187Methods for the preparation of diasteromerically pure phosphoramidate prodrugs
#188Materials and methods for prevention and treatment of viral infections
#189Methods, assays and compounds for treating bacterial infections by inhibiting methylthioinosine phosphorylase
#190Modulator of activity of adenylate cyclase
#191Glycoside derivatives and uses thereof
#192BISMUTH-THIOLS AS ANTISEPTICS FOR EPITHELIAL TISSUES, ACUTE AND CHRONIC WOUNDS, BACTERIAL BIOFILMS AND OTHER INDICATIONS
#193Glycoside compounds
#194Compositions and methods for treating pulmonary hypertension
#195Methods of inhibition of protein fucosylation in vivo using fucose analogs
#196Bile Acid Recycling Inhibitors for Treatment of Pediatric Cholestatic Liver Diseases
#197Methods for treating cancers using oral formulations of cytidine analogs
#198Bile Acid Recycling Inhibitors for Treatment of Hypercholemia and Cholestatic Liver Disease
#199PHARMACEUTICAL COMPOSITION COMPRISING A SGLT2 INHIBITOR IN COMBINATION WITH A DPP-IV INHIBITOR
#200Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions
#201Tetrahydrobenzothiophene compound
#202TABLETS CONTAINING A 1-(beta-D-GLUCOPYRANOSYL)-3-(PHENYLTHIENYLMETHYL)BENZENE COMPOUND
#203TETRAHYDROBENZOTHIOPHENE COMPOUND
#204BETA-CELL REPLICATION PROMOTING COMPOUNDS AND METHODS OF THEIR USE
#205Methods of treating breast cancer with anthracycline therapy
#206Compounds and methods for treating bacterial infections
#207Bilayer tablet formulations
#208METHODS OF DIAGNOSING AND TREATING MIGRAINE
#209Glucopyranoside compound
#210Compounds and pharmaceutical compositions for the treatment of viral infections
#211PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION
#212Effective treatment of esophogeal adenocarcinoma using triciribine and related compounds
#213Glycoside derivative and uses thereof
#214System and method for delivery of DNA-binding chemotherapy drugs using nanoparticles
#215PHARMACEUTICAL FORMULATIONS
#216Anti-microbial compositions
#217Sodium channel blocking compounds tetrodotoxin galactopyranosides
#218Purine nucleoside monophosphate prodrugs for treatment of cancer and viral infections
#219Compounds and methods for selectively targeting tumor-associated mucins
#220FORMULATION FOR CO-THERAPY TREATMENT OF DIABETES
#221METHOD FOR PREVENTING OR TREATING AMYLOID BETA PEPTIDE-ASSOCIATED DISEASES OR CONDITIONS, AND METHOD FOR INHIBITING FORMATION, ACCUMULATION OR AGGREGATION OF AMYLOID BETA PEPTIDES
#222Complex and method for enhancing nuclear delivery
#223BILE ACID RECYCLING INHIBITORS AND SATIOGENS FOR TREATMENT OF DIABETES, OBESITY, AND INFLAMMATORY GASTROINTESTINAL CONDITIONS
#224METHODS OF TREATING DERMATOLOGIC, GYNECOLOGIC, AND GENITAL DISORDERS WITH CAFFEIC ACID ANALOGS
#225SUBSTITUTED AMINE DERIVATIVE AND MEDICINAL COMPOSITION COMPRISING SAME AS THE ACTIVE INGREDIENT
#226Photokinetic ocular drug delivery methods and apparatus
#227New Therapy of Treatment of the Irritable Bowel Syndrome
#228PHARMACEUTICAL COMPOSITION COMPRISING A SGLT2 INHIBITOR IN COMBINATION WITH A DPP-IV INHIBITOR
#229Oligomeric compounds comprising tricyclic nucelosides and methods for their use
#230Methods of Treating Diseases Using Inhibitors of Nucleoside Phosphorylases and Nucleosidases
#231Metaxalone products, method of manufacture, and method of use
#232COMBINATION THERAPY FOR THE TREATMENT OF DIABETES
#233Bismuth-thiols as antiseptics for epithelial tissues, acute and chronic wounds, bacterial biofilms and other indications
#234SUBSTITUTED NUCLEOSIDE AND NUCLEOTIDE ANALOGS
#235C—glycolipids with enhanced Th-1 profile
#236Methods of treating cancer using inhibitors of 5′-methylthioadenosine phosphorylase
#237Effective treatment of esophogeal adenocarcinoma using triciribine and related compounds
#238Combination comprising CNDAC (2′-cyano-2′-deoxy-N4-palmitoyl-1-beta-D-arabinofuranosyl-cytosine) and a cytotoxic agent
#239Methods of diagnosing and treating migraine
#240Compounds and methods for treatment of solid tumors
#241Nucleoside derivatives
#242Anti-glycation methods and compositions
#243PHARMACEUTICAL COMPOSITIONS AND METHODS OF PREVENTING, TREATING, OR INHIBITING INFLAMMATORY DISEASES, DISORDERS, OR CONDITIONS OF THE SKIN, AND DISEASES, DISORDERS, OR CONDITIONS ASSOCIATED WITH COLLAGEN DEPLETION
#244METAXALONE PRODUCTS, METHOD OF MANUFACTURE, AND METHOD OF USE
#245Controlling Clostridium difficile-Associated Disease in the Gastrointestinal Tract
#246Pharmaceutical compositions and therapeutic applications for the use of a novel vitamin Bderivative, N-acetyl-L-cysteinylcobalamin
#247REVERSAL OF THE SUPPRESSIVE FUNCTION OF SPECIFIC T CELLS VIA TOLL-LIKE RECEPTOR 8 SIGNALING
#248Functional powdery product
#249Glycyrrhizin or derivatives thereof for for treating or preventing severe acute respiratory syndrome (sars)
#250Thiophene glycoside derivatives, processes for the preparation, medicaments comprising these compounds, and the use thereof
#251Use of substituted azetidinone compounds for the treatment of sitosterolemia
#252Inhibitors of proteasomal activity for stimulating hair growth
#253Treatment methods
#254Inhibitors of proteasomal activity for stimulating hair growth